FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma

Clinical trial NCT02023593 · COMPLETED

Trial details

NCT number: NCT02023593
Sponsor: Yuhong Li
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Esophageal Carcinoma

Start date: 2012-03-01
Primary completion: 2019-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.